Training in Translational Science and Cardiovascular Research
转化科学和心血管研究培训
基本信息
- 批准号:10711526
- 负责人:
- 金额:$ 52.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
ABSTRACT
This proposal seeks support for a well-established training program in translational cardiovascular research for
MD and PhD postdoctoral fellows at Oregon Health & Science University (OHSU). The training program has
a long history of training excellence and is an essential component of the educational and training activities of
The Knight Cardiovascular Institute. Over the past decade, the program has trained many fellows, who have
been successful in obtaining independent positions in academics. Our trainees included equal numbers of men
and women and MDs and PhDs, and included fellows from under-represented minority groups. We request
funding for 6 post-doctoral fellows per year (3 positions for two years each). The program offers exciting
opportunities for bench to bedside, multidisciplinary training in one of three established Training Hubs that
specialize in: 1) Cardiovascular Regulation, which includes physiological regulation, ischemia-reperfusion and
hypertension, 2) Cardiovascular Inflammation, which includes atherosclerosis, diabetes, thrombosis, and viral
infections with relevance to cardiovascular disease (including COVID-19), and 3) Cardiovascular
Development, which includes cardiovascular genetics, genomics and fetal programming. The faculty mentors
are highly recognized and funded scientists who have a strong track record of training postdoctoral fellows. The
program is highly interdisciplinary and mentors' expertise cover a wide range of the translational spectrum.
Laboratory research is supplemented by course work, seminars, journal club, and meetings within a specific
science group. Course work includes research design, biostatistics, cardiovascular physiology and genetics. All
trainees participate in responsible conduct of research training, scientific writing, entrepreneurship and team
science and leadership training. This program is unique at OHSU in that mentoring is carried out by a
multidisciplinary team, and because training is specifically designed to translate basic cardiovascular research
into clinical benefit. The primary mentor will be assisted by at least two co-mentors, who complement the primary
mentor's expertise by bringing clinical, basic science or technical expertise. The training outcome will be
scientists with a broad outlook and a focus on bringing science to the bedside. The application includes a strong
recruitment plan for underserved minority trainees and an evaluation process. A Program Advisory Committee
monitors the progress of every trainee as they meet specific mileposts in preparation for a research career. In
summary, the proposed cardiovascular research training program will provide a unique opportunity for
multidisciplinary training, and successful trainees will be well equipped to initiate independent research careers
in translational cardiovascular research.
抽象的
该建议寻求支持一项公认的培训计划,以进行转化心血管研究
俄勒冈州健康与科学大学(OHSU)的医学博士和博士博士后研究员。培训计划有
卓越训练的悠久历史,是教育和培训活动的重要组成部分
骑士心血管研究所。在过去的十年中,该计划训练了许多研究员
成功地获得了学者的独立职位。我们的学员包括同等数量的男人
以及妇女,医学博士和博士学位,包括来自代表性不足的少数群体的研究员。我们要求
每年6个博士后研究员的资金(每年3个职位,两年)。该计划提供令人兴奋的
在三个既定的培训中心之一中,卧床间,跨学科培训的机会
专门研究:1)心血管调节,其中包括生理调节,缺血 - 重新灌注和
高血压,2)心血管炎症,包括动脉粥样硬化,糖尿病,血栓形成和病毒
与心血管疾病相关的感染(包括Covid-19),3)心血管
开发,包括心血管遗传学,基因组学和胎儿编程。教师导师
是备受认可和资助的科学家,他们在训练博士后研究员方面具有良好的记录。这
计划是高度跨学科的,导师的专业知识涵盖了各种翻译光谱。
实验室研究补充了课程工作,研讨会,期刊俱乐部和特定的会议
科学小组。课程工作包括研究设计,生物统计学,心血管生理和遗传学。全部
学员参加了负责任的研究培训,科学写作,企业家精神和团队的行为
科学和领导培训。该程序在OHSU中是独一无二的,因为指导是由
多学科团队,并且因为培训是专门设计的,以翻译基本的心血管研究
进入临床益处。至少有两名副主导者将协助主要导师
通过带来临床,基础科学或技术专长,导师的专业知识。培训结果将是
具有广阔前景的科学家,专注于将科学带到床边。该应用程序包括一个强大的
服务不足的少数民族学员和评估过程的招聘计划。计划咨询委员会
在每个学员遇到特定的里程碑时,请监视每个学员的进步,以准备研究生涯。在
摘要,拟议的心血管研究培训计划将为
多学科培训和成功的学员将有能力启动独立的研究职业
在转化心血管研究中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nabil J Alkayed其他文献
Nabil J Alkayed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nabil J Alkayed', 18)}}的其他基金
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia
GPR39 作为衰老相关血管认知障碍和痴呆的治疗靶点
- 批准号:
10734713 - 财政年份:2023
- 资助金额:
$ 52.98万 - 项目类别:
Soluble Epoxide Hydrolase Inhibitor GSK2256294 for Acute Ischemic Stroke
可溶性环氧化物水解酶抑制剂 GSK2256294 用于治疗急性缺血性中风
- 批准号:
10672750 - 财政年份:2023
- 资助金额:
$ 52.98万 - 项目类别:
GPR39 as a Therapeutic Target in Subarachnoid Hemorrhage (SAH)
GPR39 作为蛛网膜下腔出血 (SAH) 的治疗靶点
- 批准号:
10478533 - 财政年份:2022
- 资助金额:
$ 52.98万 - 项目类别:
Role of GPR39 in Aging-Related Vascular Cognitive Impairment (VCI)
GPR39 在衰老相关血管认知障碍 (VCI) 中的作用
- 批准号:
10538329 - 财政年份:2022
- 资助金额:
$ 52.98万 - 项目类别:
Endothelial-Pericyte Crosstalk in Diabetic Stroke
糖尿病中风的内皮-周细胞串扰
- 批准号:
10400506 - 财政年份:2021
- 资助金额:
$ 52.98万 - 项目类别:
Pericyte phenotypic switching in diabetic post-stroke cognitive impairment (PSCI)
糖尿病中风后认知障碍(PSCI)中的周细胞表型转换
- 批准号:
10855709 - 财政年份:2018
- 资助金额:
$ 52.98万 - 项目类别:
Endothelial-Pericyte Crosstalk in Diabetic Stroke
糖尿病中风的内皮-周细胞串扰
- 批准号:
10338161 - 财政年份:2018
- 资助金额:
$ 52.98万 - 项目类别:
Neuroinflammatory Mechanisms of Vascular Cognitive Impairment
血管性认知障碍的神经炎症机制
- 批准号:
10753185 - 财政年份:2017
- 资助金额:
$ 52.98万 - 项目类别:
Neuroinflammatory mechanisms of aging-related vascular cognitive impairment (VCI)
衰老相关血管性认知障碍(VCI)的神经炎症机制
- 批准号:
9461247 - 财政年份:2017
- 资助金额:
$ 52.98万 - 项目类别:
DRα1-MOG: A Novel Immunomodulatory Therapeutic for Stroke
DRα1-MOG:一种新型中风免疫调节疗法
- 批准号:
9409245 - 财政年份:2017
- 资助金额:
$ 52.98万 - 项目类别:
相似国自然基金
CD40hiCD138hiPIR-Ahi巨噬细胞训练免疫的形成及其促进慢性排斥反应的机制研究
- 批准号:82371794
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
面向底层视觉任务的通用自监督预训练基础模型研究
- 批准号:62371164
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
认知原理启发的训练仿真系统战场空间表示方法研究
- 批准号:62306329
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支持深度伪造检测的精细化高效训练集生成方法研究
- 批准号:62372423
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
面向大规模图预训练模型的知识迁移关键问题研究
- 批准号:62376129
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
- 批准号:
10750132 - 财政年份:2024
- 资助金额:
$ 52.98万 - 项目类别:
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 52.98万 - 项目类别:
Experiences of Discrimination, Dysbiosis, and Racial Disparities in Ovarian Cancer
卵巢癌中的歧视、生态失调和种族差异的经历
- 批准号:
10371537 - 财政年份:2023
- 资助金额:
$ 52.98万 - 项目类别:
Thick and Thin Filament Dysfunction in Obese Heart Failure with Preserved Ejection Fraction
射血分数保留的肥胖性心力衰竭的粗细丝功能障碍
- 批准号:
10678204 - 财政年份:2023
- 资助金额:
$ 52.98万 - 项目类别:
Advancing Student Potential for Inclusion with Research Experiences (ASPIRE)
通过研究经验提升学生融入的潜力(ASPIRE)
- 批准号:
10678356 - 财政年份:2023
- 资助金额:
$ 52.98万 - 项目类别: